Mersana Therapeutics Inc (MRSN) — Financial Flexibility Index
Mersana Therapeutics Inc (MRSN) has a Financial Flexibility Index of -0.03x as of September 2025. Free cash flow of $-3.19 Million (operating CF $-3.19 Million minus capex $0.00) represents 0% of total liabilities ($122.22 Million). Check MRSN total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Mersana Therapeutics Inc Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Mersana Therapeutics Inc across 10 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Mersana Therapeutics Inc.
Annual Financial Flexibility Index for Mersana Therapeutics Inc (2015–2024)
Year-by-year free cash flow to debt coverage for Mersana Therapeutics Inc. Explore MRSN cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.53x | $-82.21 Million | $-82.34 Million | $154.17 Million | ▲ +39.5% |
| 2023 | -0.88x | $-166.71 Million | $-168.88 Million | $189.16 Million | ▼ -352.7% |
| 2022 | -0.19x | $-47.17 Million | $-49.36 Million | $242.28 Million | ▲ +88.2% |
| 2021 | -1.65x | $-139.34 Million | $-139.99 Million | $84.37 Million | ▼ -0.8% |
| 2020 | -1.64x | $-74.22 Million | $-74.70 Million | $45.31 Million | ▲ +28.7% |
| 2019 | -2.30x | $-67.14 Million | $-67.74 Million | $29.22 Million | ▼ -197.4% |
| 2018 | -0.77x | $-53.85 Million | $-55.22 Million | $69.71 Million | ▼ -12.9% |
| 2017 | -0.68x | $-41.54 Million | $-42.68 Million | $60.72 Million | ▼ -436.5% |
| 2016 | 0.20x | $32.67 Million | $31.59 Million | $160.71 Million | ▲ +228.7% |
| 2015 | -0.16x | $-9.02 Million | $-9.64 Million | $57.10 Million | — |